Finance

Lists
ANIK:NASDAQ
Anika Therapeutics Inc
US$ २०.४१
+०.७९%
(+०.१६) 1D
अक्टोबर १५, ०९:३०:०२ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANIK...
Open
US$ २०.४१
High
US$ २०.४१
Low
US$ २०.४१
Mkt. cap
२७.३१ करोड
Avg. vol.
८९.३६ हजार
Volume
०.००
52-wk high
US$ २२.८८
52-wk low
US$ ८.६७
EPS
-US$ ०.२७
Beta
०.२१
Shares outstanding
१.३४ करोड
No. of employees
२३५
Open
US$ २०.४१
High
US$ २०.४१
Low
US$ २०.४१
Mkt. cap
२७.३१ करोड
Avg. vol.
८९.३६ हजार
Volume
०.००
52-wk high
US$ २२.८८
52-wk low
US$ ८.६७
EPS
-US$ ०.२७
Beta
०.२१
Shares outstanding
१.३४ करोड
No. of employees
२३५
News stories
From web sources and news partners
About Anika Therapeutics Inc
CEO-
Employees२३५
Founded१९८३
HeadquartersBedford, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websiteanika.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANIK in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANIK in the last 3 months.
Highest
Current US$ २०.४१
US$ २३.०० (+१२.६९%)
Average
US$ २३.०० (+१२.६९%)
Lowest
US$ २३.०० (+१२.६९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
US$ २३.००
+१२.७%
10/01/2026
Madison Elsaadi
B. Riley Securities
Buy
Initiated
US$ २३.००
+१२.७%
09/18/2026
Anderson Schock
B. Riley Securities
Buy
Maintained
US$ २१.००
+२.९%
07/30/2026
Last report
२०२६ जुलाई २९
Fiscal period
Q2 2026
US$ ०.४२ / US$ ०.०३
+१,३००.००%beat
Revenue / Est. (USD)
३.२६ करोड / २.९२ करोड
+११.६२%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.७८ करोड
३.०६ करोड
२.९६ करोड
३.२६ करोड
Cost of goods sold
१.२२ करोड
१.१४ करोड
१.०६ करोड
१.१४ करोड
Cost of revenue
१.२२ करोड
१.१४ करोड
१.०६ करोड
१.१४ करोड
Research and development expenses
६९.४६ लाख
६४.५२ लाख
६७.१३ लाख
७३.४१ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.१९ करोड
१.२१ करोड
१.६२ करोड
१.०२ करोड
Operating expense
१.८८ करोड
१.८५ करोड
२.२९ करोड
१.७५ करोड
Total operating expenses
३.१० करोड
३.०० करोड
३.३५ करोड
२.८९ करोड
Operating income
-३२.३३ लाख
६.४६ लाख
-३९.०१ लाख
३७.२६ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-२२.३६ लाख
७.६४ लाख
-४८.२१ लाख
३३.८० लाख
EBT excluding unusual items
-२२.३६ लाख
७.६४ लाख
-३२.३४ लाख
४१.५२ लाख
Income tax expense
९.३९ लाख
-१०.३७ लाख
२.३५ लाख
७१.०० हजार
Effective tax rate
-४१.९९%
-१३५.७३%
-४.८७%
२.१०%
Other operating expenses
-
-
-
-
Net income
-२३.२९ लाख
२.९२ लाख
-५०.५६ लाख
३३.०९ लाख
Net profit margin
-८.३७%
०.९५%
-१७.०७%
१०.१५%
Earnings per share
०.०४
०.३१
०.२७
०.४२
Interest and investment income
९.९७ लाख
१.१८ लाख
६.६७ लाख
४.२६ लाख
Interest expense
-
-
-
-
Net interest expenses
९.९७ लाख
१.१८ लाख
६.६७ लाख
४.२६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१८.३० लाख
१९.६४ लाख
-२४.९४ लाख
५२.३१ लाख
Gain or loss from assets sale
-४.५१ लाख
७.९० लाख
-५२.०० हजार
-३२.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू